185 related articles for article (PubMed ID: 25453772)
1. Age and lesion-induced increases of GDNF transgene expression in brain following intracerebral injections of DNA nanoparticles.
Yurek DM; Hasselrot U; Cass WA; Sesenoglu-Laird O; Padegimas L; Cooper MJ
Neuroscience; 2015 Jan; 284():500-512. PubMed ID: 25453772
[TBL] [Abstract][Full Text] [Related]
2. Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons.
Yurek DM; Flectcher AM; Kowalczyk TH; Padegimas L; Cooper MJ
Cell Transplant; 2009; 18(10):1183-96. PubMed ID: 19650971
[TBL] [Abstract][Full Text] [Related]
3. Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.
Fletcher AM; Kowalczyk TH; Padegimas L; Cooper MJ; Yurek DM
Neuroscience; 2011 Oct; 194():220-6. PubMed ID: 21839809
[TBL] [Abstract][Full Text] [Related]
4. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
[TBL] [Abstract][Full Text] [Related]
5. Intracerebral injections of DNA nanoparticles encoding for a therapeutic gene provide partial neuroprotection in an animal model of neurodegeneration.
Yurek D; Hasselrot U; Sesenoglu-Laird O; Padegimas L; Cooper M
Nanomedicine; 2017 Oct; 13(7):2209-2217. PubMed ID: 28666950
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
7. Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism.
Chen SS; Yang C; Hao F; Li C; Lu T; Zhao LR; Duan WM
Exp Neurol; 2014 Nov; 261():87-96. PubMed ID: 24997241
[TBL] [Abstract][Full Text] [Related]
8. Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z-Q175-KI Huntington's disease mice.
Vagner T; Dvorzhak A; Wójtowicz AM; Harms C; Grantyn R
Mol Cell Neurosci; 2016 Dec; 77():76-86. PubMed ID: 27989734
[TBL] [Abstract][Full Text] [Related]
9. Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
Do Thi NA; Saillour P; Ferrero L; Paunio T; Mallet J
Gene Ther; 2007 Mar; 14(5):441-50. PubMed ID: 17093508
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke.
Kuric E; Wieloch T; Ruscher K
Exp Neurol; 2013 Sep; 247():202-8. PubMed ID: 23664961
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion.
Yurek DM; Fletcher-Turner A
Brain Res; 2001 Feb; 891(1-2):228-35. PubMed ID: 11164827
[TBL] [Abstract][Full Text] [Related]
15. Glial fibrillary acidic protein promoter determines transgene expression in satellite glial cells following intraganglionic adeno-associated virus delivery in adult rats.
Xiang H; Xu H; Fan F; Shin SM; Hogan QH; Yu H
J Neurosci Res; 2018 Mar; 96(3):436-448. PubMed ID: 28941260
[TBL] [Abstract][Full Text] [Related]
16. Targeted transgene expression in rat brain using lentiviral vectors.
Jakobsson J; Ericson C; Jansson M; Björk E; Lundberg C
J Neurosci Res; 2003 Sep; 73(6):876-85. PubMed ID: 12949915
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease.
Tereshchenko J; Maddalena A; Bähr M; Kügler S
Neurobiol Dis; 2014 May; 65():35-42. PubMed ID: 24440408
[TBL] [Abstract][Full Text] [Related]
18. Effect of nigrostriatal damage induced by 6-hydroxydopamine on the expression of glial cell line-derived neurotrophic factor in the striatum of the rat.
Mertens B; Massie A; Michotte Y; Sarre S
Neuroscience; 2009 Aug; 162(1):148-54. PubMed ID: 19383530
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism.
Segovia J; Vergara P; Brenner M
Gene Ther; 1998 Dec; 5(12):1650-5. PubMed ID: 10023444
[TBL] [Abstract][Full Text] [Related]
20. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
